1. Product information for donepezil updated to include warning of cardiac conduction disorders

   News item 19 February 2022 Pages: 1 - 1

2. Reminder that paclitaxel and nab-paclitaxel not interchangeable

   News item 19 February 2022 Pages: 2 - 2

3. Antidepressants and antipsychotics rarely associated with delirium

   Clinical study 19 February 2022 Pages: 3 - 3

4. ART-associated ADRs frequent in children with HIV infection in India

   Clinical study 19 February 2022 Pages: 4 - 4

5. FAERs, drug manufacturer databases key sources for reporting new drug safety risks

   Unknown 19 February 2022 Pages: 5 - 5

6. Increase in thromboembolic ADRs from oral contraceptives during COVID-19 pandemic in Spain

   Clinical study 19 February 2022 Pages: 6 - 6

7. Intolerance to initiation of methylphenidate infrequent in children

   Clinical study 19 February 2022 Pages: 7 - 7

8. Linezolid toxicity in patients with drug-resistant TB

   Clinical study 19 February 2022 Pages: 8 - 8

9. No adverse effects found for prenatal exposure to mRNA COVID-19 vaccine

   Clinical study 19 February 2022 Pages: 9 - 9

10. Oral corticosteroid use increases comorbidities in adults with asthma

    Clinical study 19 February 2022 Pages: 10 - 10

11. PCSK9 inhibitors associated with increase in musculoskeletal adverse events

    Clinical study 19 February 2022 Pages: 11 - 11

12. Risk of SJS/TEN highest with phenytoin, lamotrigine, allopurinol

    Clinical study 19 February 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 19 February 2022 Pages: 13 - 13

14. Abemaciclib/prednisolone

    Case report 19 February 2022 Pages: 14 - 14

15. Acetazolamide

    Case report 19 February 2022 Pages: 15 - 15

16. Acetazolamide/estrogen

    Case report 19 February 2022 Pages: 16 - 16

17. Aciclovir

    Case report 19 February 2022 Pages: 17 - 17

18. Ad26.COV2-S

    Case report 19 February 2022 Pages: 18 - 18

19. Adalimumab

    Case report 19 February 2022 Pages: 19 - 19

20. Adalimumab/azathioprine/corticosteroids

    Case report 19 February 2022 Pages: 20 - 20

21. Adalimumab/thalidomide

    Case report 19 February 2022 Pages: 21 - 21

22. Adalimumab/ustekinumab/vedolizumab

    Case report 19 February 2022 Pages: 22 - 22

23. Adenosine

    Case report 19 February 2022 Pages: 23 - 23

24. Aflibercept

    Case report 19 February 2022 Pages: 24 - 24

25. Agalsidase-beta

    Case report 19 February 2022 Pages: 25 - 25

26. Albumin-human/thalidomide

    Case report 19 February 2022 Pages: 26 - 26

27. Alcohol

    Case report 19 February 2022 Pages: 27 - 27

28. Alectinib

    Case report 19 February 2022 Pages: 28 - 28

29. Alteplase/epoprostenol

    Case report 19 February 2022 Pages: 29 - 29

30. Aminolevulinic acid/lidocaine

    Case report 19 February 2022 Pages: 30 - 30

31. Amisulpride/aripiprazole/quetiapine

    Case report 19 February 2022 Pages: 31 - 31

32. Amoxicillin/clavulanic-acid/methotrexate

    Case report 19 February 2022 Pages: 32 - 32

33. Amphotericin-B-liposomal/posaconazole

    Case report 19 February 2022 Pages: 33 - 33

34. Anastrozole

    Case report 19 February 2022 Pages: 34 - 34

35. Antiarrhythmics/beta-adrenergic-receptor-antagonists

    Case report 19 February 2022 Pages: 35 - 35

36. Antibacterials

    Case report 19 February 2022 Pages: 36 - 36

37. Antibiotics/antifungal therapy

    Case report 19 February 2022 Pages: 37 - 37

38. Antidepressants/antipsychotics/anxiolytics

    Case report 19 February 2022 Pages: 38 - 38

39. Antineoplastics

    Case report 19 February 2022 Pages: 39 - 39

40. Antineoplastics

    Case report 19 February 2022 Pages: 40 - 40

41. Antineoplastics

    Case report 19 February 2022 Pages: 41 - 41

42. Antineoplastics

    Case report 19 February 2022 Pages: 42 - 42

43. Antineoplastics

    Case report 19 February 2022 Pages: 43 - 43

44. Antineoplastics

    Case report 19 February 2022 Pages: 44 - 44

45. Antineoplastics/antibacterials

    Case report 19 February 2022 Pages: 45 - 45

46. Antineoplastics/chloroquine

    Case report 19 February 2022 Pages: 46 - 46

47. Antineoplastics/levetiracetam/pregabalin

    Case report 19 February 2022 Pages: 47 - 47

48. Antiparkinsonians

    Case report 19 February 2022 Pages: 48 - 48

49. Antirheumatics

    Case report 19 February 2022 Pages: 49 - 49

50. Antivirals

    Case report 19 February 2022 Pages: 50 - 50